Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on May 2, 2025

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

ORION OYJ         PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE         2.5.2025 KLO 15.15          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Maris-Tech Expands European Reach with New Distribution Agreement in Poland

Maris-Tech Expands European Reach with New Distribution Agreement in Poland

Collaboration with Armit Addresses Growing Demand for Defense Video …

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results

MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss …

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference

LEIDEN, Netherlands …

LGI Homes Expands Presence in Polk County with Launch of Peach Crossings in Winter Haven, Florida

LGI Homes Expands Presence in Polk County with Launch of Peach Crossings in Winter Haven, Florida

WINTER HAVEN, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- LGI Homes is excited to announce the opening of Peach Crossings, a brand-new, 52-lot community now selling in Winter Haven. Nestled in the heart of Polk County, one of Florida’s most desirable and …

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …

CareCloud Announces Preferred Stock Dividend Payments

CareCloud Announces Preferred Stock Dividend Payments

SOMERSET, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …

Dave & Buster’s Announces Board of Directors Transitions

Dave & Buster’s Announces Board of Directors Transitions

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Dave …

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (“ECOR,” “electroCore,” or the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today the completion of the merger (the “Merger”) with NeuroMetrix, …

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025

ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025

SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

Vislink Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

Mt. Olive, NJ, May 02, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (OTCQB: VISL), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and …

iBio Reports Fiscal Third Quarter 2025 Financial Results

iBio Reports Fiscal Third Quarter 2025 Financial Results

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq:IBIO), today reported financial results for the third quarter ended March 31, 2025, and provided a corporate update on its progress. “During the third quarter we were able to broaden our access …

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians

ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians

Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …

IREN to Release Q3 FY25 Results on May 14, 2025

IREN to Release Q3 FY25 Results on May 14, 2025

SYDNEY, May 02, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (together with its subsidiaries, "IREN") today announced that it will release its financial results for the three and nine-months ended March 31, 2025, on Wednesday, May 14, 2025 and host …

SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion

SCROOGE Casino Launches Revolutionary VIP Rakeback Program Amid Social Impact Expansion

Alexandria, Indiana, May 02, 2025 (GLOBE NEWSWIRE) -- SCROOGE Casino, a pioneering force in purpose-driven social gaming, announced its comprehensive VIP Rakeback Program today, set to debut in May 2025. This initiative arrives as the company continues to …

Trumpcoin ($TRUMP) Surged 30% In April As The Buzz Around Cloud Mining Grew; Investors Seeking Daily Profits With ZA Miner

Trumpcoin ($TRUMP) Surged 30% In April As The Buzz Around Cloud Mining Grew; Investors Seeking Daily Profits With ZA Miner

Middlesex, UK, May 02, 2025 (GLOBE NEWSWIRE) -- Donald Trump is turning up the heat in the crypto space, taking his involvement beyond public statements and into direct digital action. His meme coin, $TRUMP, has recently sparked major attention, shooting …

Melco Announces Earnings Release Date

Melco Announces Earnings Release Date

MACAU, May 02, 2025 (GLOBE NEWSWIRE) -- Melco Resorts …

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights

– Phase 2 TRANQUILITY trial in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease remains on track for topline data readout in the second quarter 2025 – – Tourmaline expects to provide further details on the clinical …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service